• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染与血清胃蛋白酶原水平与胃癌前病变风险的关系:中国高危胃癌人群的横断面研究。

Helicobacter pylori Infection and Serum Pepsinogen Level With the Risk of Gastric Precancerous Conditions: A Cross-sectional Study of High-risk Gastric Cancer Population in China.

机构信息

Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.

出版信息

J Clin Gastroenterol. 2021 Oct 1;55(9):778-784. doi: 10.1097/MCG.0000000000001444.

DOI:10.1097/MCG.0000000000001444
PMID:33116065
Abstract

BACKGROUND AND AIM

Gastric precancerous conditions are generally considered to play an essential role in the gastric carcinogenesis cascade. This study identified risk factors of gastric precancerous conditions in a nationwide multicenter cross-sectional study.

METHODS

Individuals who made their visit to 115 hospitals in China for gastric cancer screening were recruited. Lifestyle habits and personal information were collected through a series of questionnaires. Serum biomarker test (pepsinogen I, pepsinogen II, gastrin-17, and anti-Helicobacter pylori immunoglobulin G antibody) and endoscopy were then performed. Risk factors for gastric precancerous conditions were identified by univariate and multivariate analyses.

RESULTS

Of 14,929 subjects eligible for analysis, 4477 (30.0%) developed gastric precancerous conditions and 405 (2.71%) developed gastric cancer. In multiple logistic regression, precancerous conditions were associated with advanced age [odds ratio (OR)=1.027; 95% confidence interval (Cl), 1.023-1.032; P<0.001], male gender (OR=1.303; 95% Cl, 1.188-1.429; P<0.001), H. pylori infection (OR=1.377; 95% Cl, 1.272-1.490, P<0.001), and smoking (OR=1.142; 95% Cl, 1.005-1.298, P=0.004), whereas they were inversely correlated with white meat intake (OR=0.731; 95% Cl, 0.673-0.794; P<0.001) and pepsinogen I level (30 to 70 subgroup OR=1.536; 95% Cl, 1.163-2.028; P=0.002; <30 subgroup OR=1.354; 95% Cl, 1.206-1.520; P<0.001). Also, the authors observed a statistically lower prevalence of reflux esophagitis (2.8% vs. 4.7%) and of gastric polyps (11.0% vs. 13.7%) in H. pylori-infected population.

CONCLUSIONS

Patients with H. pylori have a 1.4-fold higher risk of having gastric precancerous conditions. Besides, precancerous conditions were associated with advanced age, male gender, H. pylori infection, and smoking in a large population. However, regular white meat intake and higher pepsinogen I level were associated with reduced risk of having precancerous lesions.

摘要

背景与目的

胃癌前病变通常被认为在胃癌发生级联反应中起着重要作用。本研究通过一项全国多中心横断面研究,确定了胃癌前病变的危险因素。

方法

本研究招募了在中国 115 家医院进行胃癌筛查的个体。通过一系列问卷收集生活方式习惯和个人信息。然后进行血清生物标志物检测(胃蛋白酶原 I、胃蛋白酶原 II、胃泌素-17 和抗幽门螺杆菌免疫球蛋白 G 抗体)和内镜检查。通过单因素和多因素分析确定胃癌前病变的危险因素。

结果

在符合分析条件的 14929 名受试者中,4477 名(30.0%)出现胃癌前病变,405 名(2.71%)出现胃癌。在多因素逻辑回归中,胃癌前病变与年龄较大[比值比(OR)=1.027;95%置信区间(Cl),1.023-1.032;P<0.001]、男性(OR=1.303;95% Cl,1.188-1.429;P<0.001)、幽门螺杆菌感染(OR=1.377;95% Cl,1.272-1.490,P<0.001)和吸烟(OR=1.142;95% Cl,1.005-1.298,P=0.004)相关,而与白肉摄入量(OR=0.731;95% Cl,0.673-0.794;P<0.001)和胃蛋白酶原 I 水平(30-70 亚组 OR=1.536;95% Cl,1.163-2.028;P=0.002;<30 亚组 OR=1.354;95% Cl,1.206-1.520;P<0.001)呈负相关。此外,作者观察到在幽门螺杆菌感染人群中,反流性食管炎(2.8% vs. 4.7%)和胃息肉(11.0% vs. 13.7%)的患病率较低。

结论

幽门螺杆菌感染患者发生胃癌前病变的风险增加 1.4 倍。此外,在大人群中,胃癌前病变与年龄较大、男性、幽门螺杆菌感染和吸烟有关。然而,定期摄入白肉和较高的胃蛋白酶原 I 水平与胃癌前病变风险降低相关。

相似文献

1
Helicobacter pylori Infection and Serum Pepsinogen Level With the Risk of Gastric Precancerous Conditions: A Cross-sectional Study of High-risk Gastric Cancer Population in China.幽门螺杆菌感染与血清胃蛋白酶原水平与胃癌前病变风险的关系:中国高危胃癌人群的横断面研究。
J Clin Gastroenterol. 2021 Oct 1;55(9):778-784. doi: 10.1097/MCG.0000000000001444.
2
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.中国高危人群中幽门螺杆菌抗体与胃癌前病变的关系
Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):627-30.
3
Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.血清生物标志物的时间变化与胃癌前病变进展风险:一项纵向研究。
Int J Cancer. 2015 Jan 15;136(2):425-34. doi: 10.1002/ijc.29005. Epub 2014 Jun 19.
4
Multicentric randomised study of eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study.根除幽门螺杆菌及胃蛋白酶原检测预防胃癌死亡的多中心随机研究:GISTAR研究
BMJ Open. 2017 Aug 11;7(8):e016999. doi: 10.1136/bmjopen-2017-016999.
5
The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.新型胃癌筛查评分系统在中国胃癌筛查及癌前病变风险评估中的应用
Scand J Gastroenterol. 2023 Jan;58(1):34-37. doi: 10.1080/00365521.2022.2099761. Epub 2022 Jul 22.
6
Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.拉脱维亚幽门螺杆菌感染和萎缩性胃炎的流行情况。
Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1410-7. doi: 10.1097/MEG.0b013e3283583ca5.
7
Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.幽门螺杆菌感染联合CagA及胃蛋白酶原状态对日本男性和女性胃癌发生的影响:一项巢式病例对照研究
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1341-7. doi: 10.1158/1055-9965.EPI-05-0901.
8
Clinical applicability of a new scoring system for population-based screening and risk factors of gastric cancer in the Wannan region.基于人群的筛查新评分系统在皖南地区的临床适用性及胃癌的危险因素
BMC Gastroenterol. 2022 Jun 23;22(1):306. doi: 10.1186/s12876-022-02384-w.
9
Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti- CagA antibodies in dyspeptic patients over 50 years old in Guilan Province, north of Iran.伊朗北部吉兰省50岁以上消化不良患者血清胃蛋白酶原、胃泌素-17、抗幽门螺杆菌和抗CagA抗体对胃癌前病变的筛查
Asian Pac J Cancer Prev. 2014;15(18):7635-8. doi: 10.7314/apjcp.2014.15.18.7635.
10
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.在中国高危地区根除幽门螺杆菌预防胃癌:一项随机对照试验。
JAMA. 2004 Jan 14;291(2):187-94. doi: 10.1001/jama.291.2.187.

引用本文的文献

1
Evaluating the detection rate and pathological features of polyps in patients with upper gastrointestinal endoscopy.评估上消化道内镜检查患者息肉的检出率及病理特征。
World J Gastrointest Endosc. 2025 May 16;17(5):105471. doi: 10.4253/wjge.v17.i5.105471.
2
Assessing Serum Pepsinogen and Tests for Detecting Diffuse-Type Gastric Cancer: Insights from a Large-Scale and Propensity-Score-Matched Study in Republic of Korea.评估血清胃蛋白酶原及检测弥漫型胃癌的试验:来自韩国一项大规模倾向评分匹配研究的见解
Cancers (Basel). 2025 Mar 12;17(6):955. doi: 10.3390/cancers17060955.
3
Gastrin-related circRNA_0017065 promotes the proliferation and metastasis of colorectal cancer through the miR-3174/RBFOX2 axis.
胃泌素相关 circRNA_0017065 通过 miR-3174/RBFOX2 轴促进结直肠癌细胞的增殖和转移。
Biol Direct. 2024 Aug 29;19(1):75. doi: 10.1186/s13062-024-00509-7.
4
Lifestyle-based nomogram for identifying the Chaoshan inhabitants of China at high risk of Helicobacter pylori infection.基于生活方式的列线图,用于识别中国潮汕地区幽门螺杆菌感染高危人群。
BMC Gastroenterol. 2023 Oct 18;23(1):359. doi: 10.1186/s12876-023-02990-2.
5
Association Between Serum Midkine Level and Gastric Precancerous Lesion in Patients with Gastritis.血清中期因子水平与胃炎患者胃癌前病变的关系。
Med Arch. 2022 Oct;76(5):368-372. doi: 10.5455/medarh.2022.76.368-372.
6
Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer.血清胃蛋白酶原和糖类抗原72-4(CA72-4)联合胃泌素-17(G-17)检测在早期胃癌筛查、诊断及评估中的应用
J Gastrointest Oncol. 2021 Jun;12(3):1042-1048. doi: 10.21037/jgo-21-254.